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Abstract: By the needs of Industry 4.0 digitalization of industry has been accentuated. 
However, cybersphysical systems left its footprints in healthcare as well, formalizing the 
cyber-medical system requirements: how to help everyday life of medical doctors and 
patients by using medical devices in a more personalized way. 
This concept meshes the entire biomedical engineering research field. The idea is to 
create mathematical algorithms able to be personalized on the patients’ need and 
physiology, use cloud computation techniques to fasten the decision support and big data 
analysis for feature extraction. As a result, the cyber-medical system concept is equivalent 
with a smart healthcare framework where by using the computational power possibilities 
together with machine learning, artificial intelligence and control engineering methods 
we would like to intensify the decision support of doctors, nurses and patients in order to 
use in an intelligent way the knowledge-based medical applications. 
The presentation will give an overview on the above-mentioned aspects: how the 
cyber-medical system concept appeared, what the trends are, how it is influencing our 
everyday’s life including education, research, medical industry and healthcare sector. In 
order to give concrete examples, individualized model-based applications are presented 
such as: 
 Artificial pancreas problem: Recent technological advances in diabetes treatment like 
Continuous Glucose Monitors (CGMs) for the subcutaneous measurement of glucose 
concentration and insulin pumps for the subcutaneous delivery of insulin allowed 
investigating the applicability of an external controller. In type 1 diabetes, where the 
disease can be characterized as a general clinical picture (e.g. complete pancreatic β-cell 
insufficiency) different individualized model-based (mostly model predictive control 
(MPC) based) solutions have been already formulated and even clinical trials appeared 
demonstrating its applicability. However, closing the loop needs the integration of 
individualized control methods and robust control algorithms in order to successfully 
reject hypoglycemic episodes. Moreover, the scientific community started to transpose 
2 L. Kovács 
 
  
the problem on type 2 diabetes as well, trying to cover the largest diabetic population with 
the artificial pancreas concept. 
 Tamed cancer concept: Beside general cancer therapies like chemotherapy, targeted 
molecular therapies appeared in order to focus on a given mechanism of the tumor growth 
stopping it in a more effective / individualized way. Antiangiogenic therapy is one 
targeted molecular therapy arose in the last decade which aims to stop tumor 
angiogenesis, i.e. formation of new blood vessels; hence, minimizing the tumor’s volume. 
However, the corresponding drugs are very expensive, and in high doses may have side 
effects; moreover, the currently used clinical protocols are determined empirically. 
Consequently, this problem can be seen as a double optimal control problem: on the one 
hand, the aim is to minimize the tumor’s volume by a model-based control algorithm, but 
it is also crucial to inject the corresponding inhibitor (drug) in an optimal way 
(minimizing costs). Due to the heterogeneous nature of the patients by a recently gained 
ERC StG grant of the European Union, we try to develop a novel concept: taming cancer. 
Beside creating a more realistic tumor growth mathematical model, we would like to 
decrease the injection sampling time of inhibitors that combined with a robust control 
method can control the tumor volume artificially and in this taming it. As a result, it would 
be even possible living with the tumor in a controlled way.  
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